Johannes B. Van Rees - Publications

Ticagrelor monotherapy versus dual antiplatelet therapy after primary percutaneous coronary intervention: one-year outcomes of the pilot STOP-IMH randomised trial.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Published: May 27, 2026

Short-term outcomes of ticagrelor monotherapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction: A randomized pilot study.

Journal: American heart journal

Published: December 04, 2025

Design and rationale of the RISC-trial: multicentre RCT to assess immediate discharge of syncope patients admitted to the (cardiac) emergency room.

Journal: European heart journal open

Published: November 26, 2025

Immediate or Deferred Nonculprit-Lesion PCI in Myocardial Infarction.

Journal: The New England journal of medicine

Published: October 29, 2025

Rationale and design of the STOP-IMH randomised trial: Safety of ticagrelor monotherapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction and the effect on intramyocardial haemorrhage.

Journal: International journal of cardiology. Heart & vasculature

Published: October 11, 2024

Bifurcation PCI with a hybrid strategy with drug- eluting balloons versus a stepwise provisional two- stent strategy: Rationale and design of the hybrid DEB study.

Journal: American heart journal

Published: July 27, 2023

Angiographic and Clinical Profile of Patients With COVID-19 Referred for Coronary Angiography During SARS-CoV-2 Outbreak: Results From a Collaborative, European, Multicenter Registry.

Journal: Angiology

Published: July 28, 2021

Difficult Vascular Access in Urgent Coronary Artery Angiogram: A Rare Case of a Persistent Sciatic Artery.

Journal: JACC. Cardiovascular interventions

Published: June 07, 2018

A breathtaking DRESS due to amoxicillin-clavulanate presenting as polymorphic eruption of the pregnancy.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: March 24, 2018

Application and comparison of the FADES, MADIT, and SHFM-D risk models for risk stratification of prophylactic implantable cardioverter-defibrillator treatment.

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Published: February 06, 2015

The clinical course of patients with implantable cardioverter-defibrillators: Extended experience on clinical outcome, device replacements, and device-related complications.

Journal: Heart rhythm

Published: January 15, 2015

Super-responders to cardiac resynchronization therapy remain at risk for ventricular arrhythmias and benefit from defibrillator treatment.

Journal: European journal of heart failure

Published: May 07, 2014